Synergy of vaccination and agonist OX40 treatment—toward a mechanism-driven combination of glioma immunotherapy

See the article by Jahan et al on pages44–54.

from Cancer via ola Kala on Inoreader http://ift.tt/2CYVn4U
via IFTTT